novo nordisk semaglutide fda withdraws application to expand use of weight loss drug Millions are trying FDA-authorized alternatives

From a mechanistic perspective, the findings reinforce the concept that GLP-1 receptor agonists exert cardiovascular benefit beyond glucose lowering, likely through integrated effects on endothelial function, inflammation, and metabolic regulation

Call our office to schedule a consultation

Anemia is a blood disorder characterized by an inadequate level of hemoglobin in the blood.

Ozempic has become popular for weight loss, but brand-name costs, gastric side effects, and supply constraints affect many patients

In a Pendulum study, after using a GLP-1 probiotic, 91% of participants experienced a decrease in appetite and 88% experienced a decrease in sugar cravings